SetPoint Medical names David Chernoff, M.D. as chief medical officer
SetPoint Medical, a clinical-stage biomedical technology company developing a bioelectronic therapy for chronic inflammatory diseases, has appointed David Chernoff, MD, as chief medical officer. Chernoff, a molecular diagnostics and biopharmaceutical











